Volume 39 Issue 2
Mar.  2018
Turn off MathJax
Article Contents
Feng Zhao, Xin-Qiang Lan, Yan Du, Pei-Yi Chen, Jiao Zhao, Fang Zhao, Wen-Hui Lee, Yun Zhang. King cobra peptide OH-CATH30 as a potential candidate drug through clinic drug-resistant isolates. Zoological Research, 2018, 39(2): 87-96. doi: 10.24272/j.issn.2095-8137.2018.025
Citation: Feng Zhao, Xin-Qiang Lan, Yan Du, Pei-Yi Chen, Jiao Zhao, Fang Zhao, Wen-Hui Lee, Yun Zhang. King cobra peptide OH-CATH30 as a potential candidate drug through clinic drug-resistant isolates. Zoological Research, 2018, 39(2): 87-96. doi: 10.24272/j.issn.2095-8137.2018.025

King cobra peptide OH-CATH30 as a potential candidate drug through clinic drug-resistant isolates

doi: 10.24272/j.issn.2095-8137.2018.025
Funds:  This work was supported by grants from the National Natural Sciences Foundation of China(31572268, 31560596), the Key Research Program of the Chinese Academy of Sciences (KJZD-EW-L03), "Yunnan Scholar" Program, the Yunnan Applied Basic Research Projects (2016FD076), the National Training Program of Innovation and Entrepreneurship for Undergraduates (201510685001, 201610685001), and Puer University (RCXM003 & CXTD011)
More Information
  • Corresponding author: Feng Zhao,Yun Zhang,E-mail: zhaofeng@mail.kiz.ac.cn; zhangy@mail.kiz.ac.cn
  • Received Date: 2017-12-01
  • Rev Recd Date: 2018-02-08
  • Publish Date: 2018-03-18
  • Cationic antimicrobial peptides (AMPs) are considered as important candidate therapeutic agents, which exert potent microbicidal properties against bacteria, fungi and some viruses. Based on our previous findings king cobra cathelicidin (OH-CATH) is a 34-amino acid peptide that exerts strong antibacterial and weak hemolytic activity. The aim of this research is to evaluate the efficacy of both OH-CATH30 and its analog D-OH-CATH30 against clinical isolates comparing with routinely utilized antibiotics in vitro. In this study, 584 clinical isolates were tested (spanning 2013–2016) and the efficacy of the candidate peptides and antibiotics were determined by a broth microdilution method according to the CLSI guidelines. Among the 584 clinical isolates, 85% were susceptible to OH-CATH30 and its analogs. Both L- and D-OH-CATH30 showed higher efficacy against (toward) Gram-positive bacteria and stronger antibacterial activity against nearly all Gram-negative bacteria tested compare with antibiotics. The highest bactericidal activity was detected against Acinetobacter spp., including multi-drug-resistant Acinetobacter baumannii (MRAB) and methicillin-resistant Staphylococcus aureus (MRSA). The overall efficacy of OH-CATH30 and its analogs was higher than that of the 9 routinely used antibiotics. OH-CATH30 is a promising candidate drug for the treatment of a wide variety of bacterial infections which are resistant to many routinely used antimicrobial agents.
  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (954) PDF downloads(479) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return